III 109th CONGRESS 1st Session S. RES. 101 IN THE SENATE OF THE UNITED STATES April 6, 2005 Mr. Santorum (for himself, Mr. Specter, and Mr. Lautenberg) submitted the following resolution; which was considered and agreed to RESOLUTION Recognizing the 50th anniversary of the development of the Salk polio vaccine and its importance in eradicating the incidence of polio.

Whereas the epidemic of polio struck the citizens of the United States in the early 1950s, causing thousands of cases of lingering paralysis and death; Whereas the epidemic of polio peaked in 1952, having affected nearly 58,000 people, mainly children and young adults; Whereas many of those affected by polio needed the assistance of mechanical ventilators in order to breathe, while others were crippled and dependent upon crutches for mobility; Whereas University of Pittsburgh faculty member Dr. Jonas Salk and his team of researchers developed the first vaccine against polio; Whereas, in April 1955, the results of an unprecedented and successful nationwide clinical trial of the polio vaccine were announced; and Whereas the Salk polio vaccine was approved for widespread public use at that time: Now, therefore, be it

That the Senate— (1) recognizes the pioneering achievement of Dr. Jonas Salk and his team of researchers at the University of Pittsburgh in the development of the Salk polio vaccine; (2) expresses its appreciation to— (A) the family of Dr. Salk for the elimination of polio, a disease that caused countless deaths and disabling consequences; (B) the members of Dr. Salk's research team; and (C) the individuals who generously agreed to participate in clinical trials to validate the efficacy of the polio vaccine; and (3) celebrates with the University of Pittsburgh on the 50th anniversary of the approval and use of the Salk polio vaccine.